Cargando…
Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway
Has_circ_0008583 is reported to be involved in the progression of hepatocellular carcinoma (HCC), while its biological role in HCC remains unclear. Here, the qRT-PCR was used to detect the expression of has_circ_0008583. The CCK-8 kit was performed to measure cell proliferation. The cell migration a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805961/ https://www.ncbi.nlm.nih.gov/pubmed/35258395 http://dx.doi.org/10.1080/21655979.2021.2017579 |
_version_ | 1784643339376656384 |
---|---|
author | Wang, Fenfen Xie, Zhengyuan Zhang, Nuobei Ding, Hao Xiong, Kai Guo, Li Huang, Hongyan Wen, Zhili |
author_facet | Wang, Fenfen Xie, Zhengyuan Zhang, Nuobei Ding, Hao Xiong, Kai Guo, Li Huang, Hongyan Wen, Zhili |
author_sort | Wang, Fenfen |
collection | PubMed |
description | Has_circ_0008583 is reported to be involved in the progression of hepatocellular carcinoma (HCC), while its biological role in HCC remains unclear. Here, the qRT-PCR was used to detect the expression of has_circ_0008583. The CCK-8 kit was performed to measure cell proliferation. The cell migration and invasion were evaluated by Transwell. A dual-luciferase reporter assay was performed to confirm the target combination between the genes in has_circ_0008583/miR-1301-3p/METTL3 axis. The in vivo role of has_circ_0008583 was verified by murine xenograft assay. Our data showed that hsa_circ_0008583 was upregulated in HCC tissues and cells. Hsa_circ_0008583 overexpression promoted Hep3B cell proliferation, migration and invasion, but hsa_circ_0008583 silencing had an opposing influence. MiR-1301-3p is directly bound to hsa_circ_0008583 and METTL3. MiR-1301-3p overexpression or METTL3 knockdown could partially counteract hsa_circ_0008583 overexpression-mediated influence on HCC cell behaviors. In addition, hsa_circ_0008583 depletion inhibits HCC tumor growth in vivo. In conclusion, hsa_circ_0008583 promotes HCC progression through the miR-1301-3p/METTL3 axis. |
format | Online Article Text |
id | pubmed-8805961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-88059612022-02-02 Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway Wang, Fenfen Xie, Zhengyuan Zhang, Nuobei Ding, Hao Xiong, Kai Guo, Li Huang, Hongyan Wen, Zhili Bioengineered Research Paper Has_circ_0008583 is reported to be involved in the progression of hepatocellular carcinoma (HCC), while its biological role in HCC remains unclear. Here, the qRT-PCR was used to detect the expression of has_circ_0008583. The CCK-8 kit was performed to measure cell proliferation. The cell migration and invasion were evaluated by Transwell. A dual-luciferase reporter assay was performed to confirm the target combination between the genes in has_circ_0008583/miR-1301-3p/METTL3 axis. The in vivo role of has_circ_0008583 was verified by murine xenograft assay. Our data showed that hsa_circ_0008583 was upregulated in HCC tissues and cells. Hsa_circ_0008583 overexpression promoted Hep3B cell proliferation, migration and invasion, but hsa_circ_0008583 silencing had an opposing influence. MiR-1301-3p is directly bound to hsa_circ_0008583 and METTL3. MiR-1301-3p overexpression or METTL3 knockdown could partially counteract hsa_circ_0008583 overexpression-mediated influence on HCC cell behaviors. In addition, hsa_circ_0008583 depletion inhibits HCC tumor growth in vivo. In conclusion, hsa_circ_0008583 promotes HCC progression through the miR-1301-3p/METTL3 axis. Taylor & Francis 2022-01-04 /pmc/articles/PMC8805961/ /pubmed/35258395 http://dx.doi.org/10.1080/21655979.2021.2017579 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Wang, Fenfen Xie, Zhengyuan Zhang, Nuobei Ding, Hao Xiong, Kai Guo, Li Huang, Hongyan Wen, Zhili Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway |
title | Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway |
title_full | Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway |
title_fullStr | Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway |
title_full_unstemmed | Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway |
title_short | Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway |
title_sort | has_circ_0008583 modulates hepatocellular carcinoma progression through the mir-1301-3p/mettl3 pathway |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805961/ https://www.ncbi.nlm.nih.gov/pubmed/35258395 http://dx.doi.org/10.1080/21655979.2021.2017579 |
work_keys_str_mv | AT wangfenfen hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway AT xiezhengyuan hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway AT zhangnuobei hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway AT dinghao hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway AT xiongkai hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway AT guoli hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway AT huanghongyan hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway AT wenzhili hascirc0008583modulateshepatocellularcarcinomaprogressionthroughthemir13013pmettl3pathway |